Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Parkinson's patients watch their own best moves in VR to fight slowness

NCT ID NCT07250672

Symptom relief Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether Parkinson's patients can improve their movement by watching personalized 3D virtual reality recordings of their own smooth, fast actions. 24 participants will use VR headsets to view their own best movement sequences, aiming to retrain the brain and reduce bradykinesia (slowness). The trial focuses on symptom ease, not a cure, and is in an early, exploratory phase.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Immersive virtual reality action observation training using patient-specific 3D motion recordings
What this could lead to
If it works, this could offer a new, non-drug way to help Parkinson's patients move more easily by retraining their brain through personalized VR.
What could go wrong
This is a very small, early-stage trial (24 people) with no comparison group, so results may not be generalizable. The benefit may be small or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Voluntary agreement to participate in the study * Clinical diagnosis of Parkinson's disease confirmed by a neurologist * Ongoing treatment with antiparkinsonian medication * Hoehn and Yahr (H-Y) stage ≤ 3 * Ability to walk independently Exclusion Criteria: * Presence of additional neurological disorders other than Parkinson's disease * Change in medication dosage within the past month * Score of ≥ 10 on the Simulator Sickness Questionnaire * Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision * Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 3D recording are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

3D recording Action obervation training Immersive virtual reality Parkinson disease Virtual reality

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Abant Izzet Baysal University Faculty of Health Science

    RECRUITING

    Bolu, Bolu, 14100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.